Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage

Journal article

Open access

Peer reviewed

H P Adams Jr

Stroke (1970), Vol.13(2), pp.256-259

03/1982

DOI: 10.1161/01.STR.13.2.256

PMID: 7039006

Files and links (1)

url

https://doi.org/10.1161/01.STR.13.2.256View

Published (Version of record) Open Access

no abstract

Antifibrinolytic Agents - therapeutic use

Recurrence

Bed Rest

Humans

Intracranial Aneurysm - complications

Subarachnoid Hemorrhage - complications

Tranexamic Acid - therapeutic use

Diarrhea - chemically induced

Hypotension - chemically induced

Tranexamic Acid - adverse effects

Intracranial Aneurysm - surgery

Ischemic Attack, Transient - complications

Aminocaproates - blood

Hydrocephalus - chemically induced

Subarachnoid Hemorrhage - mortality

Nervous System Diseases - chemically induced

Muscular Diseases - chemically induced

Aminocaproates - therapeutic use

Intracranial Aneurysm - drug therapy

Aminocaproates - urine

Cerebrospinal Fluid - physiology

Subarachnoid Hemorrhage - drug therapy

Title: Subtitle: Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage
Creators: H P Adams Jr
Resource Type: Journal article
Publication Details: Stroke (1970), Vol.13(2), pp.256-259
Publisher: United States
DOI: 10.1161/01.STR.13.2.256
PMID: 7039006
ISSN: 0039-2499
eISSN: 1524-4628
Language: English
Date published: 03/1982
Academic Unit: Neurology; Iowa Neuroscience Institute
Record Identifier: 9984020720802771

9 Record Views